tiprankstipranks
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market
OBIO
Orchestra BioMed Holdings
RESEARCH TOOLSreports

Orchestra BioMed Holdings (OBIO) Financial Statements

100 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently $253.98M. The company's EPS TTM is $0.118; its P/E ratio is -3,008.78; Orchestra BioMed Holdings is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 33.48M$ 2.64M$ 2.76M$ 3.53M$ -782.00K
Gross Profit$ 33.29M$ 2.43M$ 2.57M$ 3.21M$ -981.00K
Operating Income$ -51.81M$ -64.30M$ -51.51M$ -32.66M$ -21.80M
EBITDA$ -51.48M$ -63.99M$ -51.22M$ -32.44M$ -21.62M
Net Income$ -52.95M$ -61.02M$ -49.12M$ -33.61M$ -23.01M
Balance Sheet
Cash & Short-Term Investments$ 106.51M$ 66.81M$ 87.59M$ 83.78M$ 10.90M
Total Assets$ 114.86M$ 76.17M$ 95.21M$ 95.57M$ 13.53M
Total Debt$ 1.69M$ 16.53M$ 1.69M$ 11.87M$ 5.67M
Net Debt$ -33.00M$ -5.73M$ -28.87M$ -7.91M$ -4.26M
Total Liabilities$ 51.48M$ 43.22M$ 27.17M$ 43.04M$ 84.76M
Stockholders' Equity$ 63.38M$ 32.96M$ 68.04M$ 52.53M$ -71.23M
Cash Flow
Free Cash Flow$ -49.45M$ -50.85M$ -46.20M$ -29.88M$ -19.70M
Operating Cash Flow$ -48.96M$ -50.56M$ -46.13M$ -29.29M$ -19.43M
Investing Cash Flow$ -26.94M$ 13.09M$ 10.69M$ -64.12M$ 13.02M
Financing Cash Flow$ 88.33M$ 29.17M$ 46.22M$ 103.26M$ -3.99M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Income Statement >

Orchestra BioMed Holdings Debt to Assets

Balance Sheet >

Orchestra BioMed Holdings Cash Flow

Cash Flow >

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

Earnings >